Medical Crossfire®: Recognizing and Treating VTE in Patients With Cancer - Bridging Guideline-Based Recommendations With Real-World Evidence

Medical Crossfire®: Recognizing and Treating Venous Thromboembolism (VTE) in Patients With Cancer - Bridging Guideline-Based Recommendations With Real-World Evidence is organized by Physicians' Education Resource, LLC (PER).

Release Date: January 31, 2020
Expiration Date: January 31, 2021

Accreditation:
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Activity Overview:
As cancer incidence rates remain high, so does the risk of disease- or treatment-related complications, such as venous thromboembolism (VTE), leading to devastating functional losses and even death. In fact, VTE, comprising deep vein thrombosis (DVT) and pulmonary embolism (PE), occurs 4- to 7-fold higher in patients with cancer compared with the general population. Because several different types of cancer are associated with a higher risk of clot formation, management of VTE requires a multidisciplinary approach to treatment and prophylaxis. It is imperative for oncologists and hematologists to have knowledge of VTE risk factors and stratification, management strategies using low-molecular weight heparins or direct oral anticoagulants, guideline-based recommendations for care, and methods for reducing recurrence following initial treatment.

This Medical Crossfire®: Recognizing and Treating VTE in Patients With Cancer - Bridging Guideline-Based Recommendations With Real-World Evidence online CME activity delivers opinions, insights, and philosophies from 3 experts in oncology and hematology who are well versed in the treatment of cancers that are associated with a high risk of VTE. A didactic overview of incidence, risk assessment, and guideline updates is followed by case presentations to assist in the application of key strategies into defined patient care scenarios. Case-based educational programs help clinicians not just understand the evolving data, but also incorporate new information into clinical practice in order to individualize VTE treatment and prevention for their patients with cancer.

Benefits of Participating:
• Appreciate the impact that cancer-related VTE has on patients’ lives
• Improve your knowledge on how to identify patients who might be at high-risk of developing cancer-related VTE
• Gain awareness of best practices for managing and treating patients with cancer-related VTE
• Learn how the experts handle challenging, real-world clinical cases

Learning Objectives:
Upon successful completion of this educational activity, you should be better prepared to:
• Recognize the prevalence, morbidity, and mortality rates as well as risk factors associated with development of VTE in patients with cancer.
• Apply recent evidence-based guideline recommendations for the prevention and treatment of cancer-associated VTE into clinical practice.
• Identify strategies for the prevention and treatment of VTE in patients with cancer, including the reduction of risk of recurrence following initial treatment.
• Implement individualized anticoagulation regimens for prevention and treatment of VTE in patients with cancer that are based on the unique needs and characteristics of each patient.